Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

36.90
-1.2000-3.15%
Post-market: 36.900.00000.00%19:30 EDT
Volume:1.03M
Turnover:38.64M
Market Cap:2.90B
PE:-8.50
High:38.59
Open:38.39
Low:36.84
Close:38.10
52wk High:45.14
52wk Low:22.10
Shares:78.49M
Float Shares:73.02M
Volume Ratio:1.61
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3401
EPS(LYR):-3.9000
ROE:-43.88%
ROA:-27.62%
PB:4.05
PE(LYR):-9.46

Loading ...

Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress

GlobeNewswire
·
Jun 11

Celldex Therapeutics Is Maintained at Buy by UBS

Dow Jones
·
Jun 11

UBS Adjusts Price Target on Celldex Therapeutics to $45 From $38, Maintains Buy Rating

MT Newswires Live
·
Jun 10

Celldex price target raised to $45 from $38 at UBS

TIPRANKS
·
Jun 10

U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle

Reuters
·
Jun 10

A Look At Celldex Therapeutics (CLDX) Valuation After Recent Share Price Pullback And Mixed P/B And DCF Signals

Simply Wall St.
·
Jun 10

Celldex publishes investor presentation highlighting barzolvolimab late-stage urticaria trials and broader mast cell disease pipeline

Reuters
·
May 28

Celldex Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
May 13

U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic

Reuters
·
May 13

The Bull Case For Celldex Therapeutics (CLDX) Could Change Following Q1 Loss And Barzolvolimab Milestones

Simply Wall St.
·
May 12

Celldex Therapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
May 08

Celldex Therapeutics Inc expected to post a loss of $1.15 a share - Earnings Preview

Reuters
·
May 08

Celldex price target raised to $48 from $45 at Barclays

TIPRANKS
·
May 08

Analysts Are Bullish on These Healthcare Stocks: Tectonic Therapeutic (TECX), Celldex (CLDX)

TIPRANKS
·
May 08

Celldex Therapeutics Q1 EPS $(1.18) Beats $(1.20) Estimate, Sales $15.000K Miss $972.222K Estimate

Benzinga Earnings
·
May 08

Celldex Q1 net loss widens to $78.7 million; R&D expenses rise to $73 million

Reuters
·
May 08

Celldex Therapeutics Q1 Operating Income USD -84.435 Million

THOMSON REUTERS
·
May 08

Celldex Reports First Quarter Financial Results and Provides Corporate Update

GlobeNewswire
·
May 08

Assessing Celldex Therapeutics (CLDX) Valuation After Strong Recent Share Price Gains

Simply Wall St.
·
Apr 22

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20